152 related articles for article (PubMed ID: 17392503)
1. Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma.
Damm-Welk C; Busch K; Burkhardt B; Schieferstein J; Viehmann S; Oschlies I; Klapper W; Zimmermann M; Harbott J; Reiter A; Woessmann W
Blood; 2007 Jul; 110(2):670-7. PubMed ID: 17392503
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of the NPM-ALK fusion gene in bone marrow and peripheral blood for patients with anaplastic large cell lymphoma].
Yang J; Zhao XX; Jin L; Duan YL; Huang S; Zhang M; Zhang R; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):700-3. PubMed ID: 23978023
[TBL] [Abstract][Full Text] [Related]
3. Quantitative PCR detection of NPM/ALK fusion gene and CD30 gene expression in patients with anaplastic large cell lymphoma--residual disease monitoring and a correlation with the disease status.
Kalinova M; Krskova L; Brizova H; Kabickova E; Kepak T; Kodet R
Leuk Res; 2008 Jan; 32(1):25-32. PubMed ID: 17320171
[TBL] [Abstract][Full Text] [Related]
4. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
5. Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for
Damm-Welk C; Kutscher N; Zimmermann M; Attarbaschi A; Schieferstein J; Knörr F; Oschlies I; Klapper W; Woessmann W
Haematologica; 2020 Aug; 105(8):2141-2149. PubMed ID: 31649129
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
Damm-Welk C; Schieferstein J; Schwalm S; Reiter A; Woessmann W
Br J Haematol; 2007 Aug; 138(4):459-66. PubMed ID: 17608768
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma.
Mussolin L; Pillon M; d'Amore ES; Santoro N; Lombardi A; Fagioli F; Zanesco L; Rosolen A
Leukemia; 2005 Sep; 19(9):1643-7. PubMed ID: 16049513
[TBL] [Abstract][Full Text] [Related]
8. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma.
Li C; Takino H; Eimoto T; Ishida T; Inagaki A; Ueda R; Suzuki R; Yoshino T; Nakagawa A; Nakamura S; Inagaki H
Mod Pathol; 2007 Jun; 20(6):648-55. PubMed ID: 17464320
[TBL] [Abstract][Full Text] [Related]
10. Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.
Damm-Welk C; Mussolin L; Zimmermann M; Pillon M; Klapper W; Oschlies I; d'Amore ES; Reiter A; Woessmann W; Rosolen A
Blood; 2014 Jan; 123(3):334-7. PubMed ID: 24297868
[TBL] [Abstract][Full Text] [Related]
11. The t(2;5) in human lymphomas.
Kadin ME; Morris SW
Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
[TBL] [Abstract][Full Text] [Related]
12. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma.
Iijima-Yamashita Y; Mori T; Nakazawa A; Fukano R; Takimoto T; Tsurusawa M; Kobayashi R; Horibe K
Int J Hematol; 2018 Feb; 107(2):244-250. PubMed ID: 29030834
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL).
Ritter U; Damm-Welk C; Fuchs U; Bohle RM; Borkhardt A; Woessmann W
Oligonucleotides; 2003; 13(5):365-73. PubMed ID: 15000827
[TBL] [Abstract][Full Text] [Related]
15. Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns.
Ladanyi M; Cavalchire G
Diagn Mol Pathol; 1996 Sep; 5(3):154-8. PubMed ID: 8866227
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity.
Cussac D; Greenland C; Roche S; Bai RY; Duyster J; Morris SW; Delsol G; Allouche M; Payrastre B
Blood; 2004 Feb; 103(4):1464-71. PubMed ID: 14563642
[TBL] [Abstract][Full Text] [Related]
17. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
Hsu FY; Johnston PB; Burke KA; Zhao Y
Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
[TBL] [Abstract][Full Text] [Related]
19. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
[TBL] [Abstract][Full Text] [Related]
20. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
